Suppr超能文献

体外诊断 T 细胞介导的药物过敏。

In vitro diagnosis of T cell-mediated drug allergy.

机构信息

Department of Rheumatology, Clinical Immunology and Allergology, University Bern, Bern, Switzerland.

出版信息

Clin Exp Allergy. 2011 Apr;41(4):461-70. doi: 10.1111/j.1365-2222.2011.03701.x. Epub 2011 Feb 22.

Abstract

Diagnosis of drug hypersensitivity relies on history, skin tests, in vitro tests and provocation tests. In vitro tests are of great interest, due to possible reduction of drug provocation tests. In this review we focus on best investigated in vitro techniques for the diagnosis of T cell-mediated drug hypersensitivity reactions. As drug hypersensitivity relies on different pathomechanisms and as a single diagnostic test usually does not cover all possible reactions, it is advisable to combine different tests to increase the overall sensitivity. Recently, proliferation-based assays have been supplemented by a panel of novel in vitro tests including analysis of cytotoxic potential of effector cells (granzyme B, granulysin, CD107a), evaluation of cytokine secretion (IL-2, IL-5, IL-13, and IFN-γ) and up-regulation of cell surface activation markers (CD69). We discuss the latest findings and readout systems to identify causative drugs by detecting functional and phenotypic markers of drug-reacting cells, and their ability to enable a more conclusive diagnosis of drug allergy.

摘要

药物过敏反应的诊断依赖于病史、皮肤试验、体外试验和激发试验。由于可能减少药物激发试验,体外试验具有很大的研究意义。在本综述中,我们重点介绍了用于诊断 T 细胞介导的药物过敏反应的研究最多的体外技术。由于药物过敏反应依赖于不同的发病机制,并且单一诊断测试通常不能涵盖所有可能的反应,因此建议结合使用不同的测试以提高整体敏感性。最近,基于增殖的检测方法已经通过一系列新的体外检测方法得到了补充,包括效应细胞(颗粒酶 B、颗粒溶素、CD107a)的细胞毒性潜能分析、细胞因子分泌(IL-2、IL-5、IL-13 和 IFN-γ)的评估以及细胞表面激活标志物(CD69)的上调。我们讨论了最新的发现和读出系统,通过检测药物反应细胞的功能和表型标志物及其对药物过敏更明确诊断的能力,来识别致敏药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验